Precise pathological classification of non-small cell lung adenocarcinoma and squamous carcinoma based on an integrated platform of targeted metabolome and …

P Cao, S Wu, W Guo, Q Zhang, W Gong, Q Li, R Zhang… - Metabolomics, 2021 - Springer
Background Non-small cell lung cancer (NSCLC) is the leading cause of cancer-related
death worldwide. Lung adenocarcinoma (LUAD) and squamous cell carcinoma (LUSC) are …

Loading and release of cancer chemotherapy drugs utilizing simultaneous temperature and pH-responsive nanohybrid

M Dahri, H Akbarialiabad, AM Jahromi… - BMC Pharmacology and …, 2021 - Springer
Background Recently, the development of nanocarriers and the improvement of their
biochemical properties have became of great importance. Single-walled carbon nanotubes …

PD‐L1 and CD47 co‐expression predicts survival and enlightens future dual‐targeting immunotherapy in non‐small cell lung cancer

Z Yang, Y Peng, W Guo, J Xu, L Li, H Tian, R Li… - Thoracic …, 2021 - Wiley Online Library
Backgroud Recent studies have indicated that programmed cell death‐ligand 1 (PD‐L1) and
cluster of differentiation 47 (CD47) play an essential role in tumor immune evasion and may …

Construction and validation of prognosis nomogram for metastatic lung squamous cell carcinoma: a population-based study

Y Liu, M Sun, Y Xiong, X Gu… - Technology in Cancer …, 2022 - journals.sagepub.com
Purpose: This study aimed to establish a nomogram to predict overall survival in lung
squamous cell carcinoma patients with metastasis for clinical decision-making. Methods: We …

[HTML][HTML] Squamous cell carcinoma predicts worse prognosis than adenocarcinoma in stage IA lung cancer patients: A population-based propensity score matching …

B Hao, F Li, X Wan, S Pan, D Li, C Song, N Li… - Frontiers in …, 2022 - frontiersin.org
Background: Although numerous studies have reported the association between histological
types and the prognosis of ⅠA non-small lung cancer (NSCLC) patients, few studies deeply …

A Comparative Study of Amide Proton Transfer Weighted Imaging and Intravoxel Incoherent Motion MRI Techniques Versus (18) F‐FDG PET to Distinguish Solitary …

T Fang, N Meng, P Feng, Z Huang, Z Li… - Journal of Magnetic …, 2022 - Wiley Online Library
Background Amide proton transfer weighted imaging (APTw), intravoxel incoherent motion
(IVIM), and positron emission tomography (PET) imaging all have the potential to …

First insight about the ability of specific glycerophospholipids to discriminate non-small cell lung cancer subtypes

J Sieminska, K Miniewska, R Mroz, E Sierko… - Frontiers in Molecular …, 2024 - frontiersin.org
Introduction: Discrimination between adenocarcinoma (ADC) and squamous cell carcinoma
(SCC) subtypes in non-small cell lung cancer (NSCLC) patients is a significant challenge in …

Overexpression of SFXN1 indicates poor prognosis and promotes tumor progression in lung adenocarcinoma

L Chen, Y Kang, Y Jiang, J You, C Huang, X Xu… - … -Research and Practice, 2022 - Elsevier
Abstract Sideroflexin 1 (SFXN1) functions as a mitochondrial serine transporter in one-
carbon metabolism. The association between SFXN1 and tumorigenesis remains to be …

Differential diagnosis of localized pneumonic-type lung adenocarcinoma and pulmonary inflammatory lesion

Q Li, X Fan, J Huo, T Luo, X Huang, J Gong - Insights into Imaging, 2022 - Springer
Background In clinical practice, a number of delayed diagnoses of localized pneumonic-type
lung adenocarcinoma (L-PLADC) mimicking pneumonia have been identified due to the …

TFAP2A-induced SLC2A1-AS1 promotes cancer cell proliferation

Y Cui, C Zhang, S Ma, F Guan - Biological chemistry, 2021 - degruyter.com
Long non-coding RNAs (lncRNAs) are involved in the occurrence and development of
human cancers including lung adenocarcinoma (LUAD). SLC2A1-AS1 is a novel lncRNA …